Fucibet cream

Fucibet is a specialized dermatological cream containing a combination of fusidic acid (an antibiotic) and betamethasone (a corticosteroid). It is primarily used to treat inflammatory skin conditions where a bacterial infection is also present. The brand is part of the core portfolio of LEO Pharma, a company with deep roots in medical research and dermatology.

Originally developed in Denmark by LEO Pharma, the product is manufactured at various global sites under high pharmaceutical standards, with a significant manufacturing hub located in Dublin, Ireland. The brand remains under the ownership of LEO Pharma, which is controlled by the LEO Foundation, ensuring that the company operates as an independent, research-driven entity focused on skin health globally.